Mogo Schedules Q1 2022 Earnings Conference Call

VANCOUVER, British Columbia--(BUSINESS WIRE)-- Mogo Inc. (TSX: MOGO) (NASDAQ: MOGO) (“Mogo” or the “Company”), a digital payments and financial technology company, today announced it will hold a conference call and webcast to discuss its Q1 2022 financial results on Thursday, May 12, 2022 at 3:00 p.m. ET. The call will be hosted by David Feller, Mogo’s Founder & CEO, and Greg Feller, President & CFO. The live webcast will include a slide presentation. The Company will issue its financial results prior to market open on May 12.

About Mogo

Mogo Inc., one of Canada’s leading financial technology companies, is empowering its 1.9 million members with simple digital solutions to help them get in control of their financial health while also making a positive impact with their money. Through the free Mogo app, consumers can access a digital spending account with Mogo Visa* Platinum Prepaid Card featuring automatic carbon offsetting, easily buy and sell bitcoin, get free monthly credit score monitoring and ID fraud protection and access personal loans and mortgages. Mogo’s new MogoTrade app offers commission-free stock trading that helps users make a positive impact with every investment and together with Moka, Mogo’s wholly-owned subsidiary bringing automated, fully-managed flat-fee investing to Canadians, forms the heart of Mogo’s digital wealth platform. Mogo’s wholly-owned subsidiary, Carta Worldwide, also offers a digital payments platform that powers the next-generation card programs from innovative fintech companies in Europe, North America and APAC. To learn more, please visit mogo.ca or download the mobile app (iOS or Android).

View source version on businesswire.com: https://www.businesswire.com/news/home/20220503005865/en/

For further information:
US Investor Relations Contact
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
[email protected]

Craig Armitage
Investor Relations
[email protected]
(416) 347-8954

Source: Mogo Inc.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Irenic Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 18, 2026
• FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Ce